feat(admin): Add user management and upgrade to module permission system
Features - User Management (Phase 4.1): - Database: Add user_modules table for fine-grained module permissions - Database: Add 4 user permissions (view/create/edit/delete) to role_permissions - Backend: UserService (780 lines) - CRUD with tenant isolation - Backend: UserController + UserRoutes (648 lines) - 13 API endpoints - Backend: Batch import users from Excel - Frontend: UserListPage (412 lines) - list/filter/search/pagination - Frontend: UserFormPage (341 lines) - create/edit with module config - Frontend: UserDetailPage (393 lines) - details/tenant/module management - Frontend: 3 modal components (592 lines) - import/assign/configure - API: GET/POST/PUT/DELETE /api/admin/users/* endpoints Architecture Upgrade - Module Permission System: - Backend: Add getUserModules() method in auth.service - Backend: Login API returns modules array in user object - Frontend: AuthContext adds hasModule() method - Frontend: Navigation filters modules based on user.modules - Frontend: RouteGuard checks requiredModule instead of requiredVersion - Frontend: Remove deprecated version-based permission system - UX: Only show accessible modules in navigation (clean UI) - UX: Smart redirect after login (avoid 403 for regular users) Fixes: - Fix UTF-8 encoding corruption in ~100 docs files - Fix pageSize type conversion in userService (String to Number) - Fix authUser undefined error in TopNavigation - Fix login redirect logic with role-based access check - Update Git commit guidelines v1.2 with UTF-8 safety rules Database Changes: - CREATE TABLE user_modules (user_id, tenant_id, module_code, is_enabled) - ADD UNIQUE CONSTRAINT (user_id, tenant_id, module_code) - INSERT 4 permissions + role assignments - UPDATE PUBLIC tenant with 8 module subscriptions Technical: - Backend: 5 new files (~2400 lines) - Frontend: 10 new files (~2500 lines) - Docs: 1 development record + 2 status updates + 1 guideline update - Total: ~4900 lines of code Status: User management 100% complete, module permission system operational
This commit is contained in:
@@ -2,41 +2,41 @@
|
||||
|
||||
**测试日期**: 2025-11-18
|
||||
**测试目的**: 确定准确率不高的根本原因
|
||||
**瘚贝<EFBFBD><EFBFBD>寞<EFBFBD>**: 銝斗郊瘚贝<EFBFBD>瘜?
|
||||
**测试方法**: 两步测试法
|
||||
|
||||
---
|
||||
|
||||
## 📊 测试结果总览
|
||||
|
||||
### 蝚?甇伐<E79487><E4BC90>賢<EFBFBD> vs <20>賡<EFBFBD>璅∪<E79285>撖寞<E69296>
|
||||
### 第1步:国内 vs 国际模型对比
|
||||
|
||||
| 璅∪<EFBFBD>蝏<EFBFBD><EFBFBD> | <20><>&<EFBFBD>?| 銝<><E98A9D>渡<EFBFBD> | 撟喳<E6929F><E596B3>埈𧒄 | JSON蝔喳<EFBFBD><EFBFBD>?|
|
||||
| 模型组合 | 准确率 | 一致率 | 平均耗时 | JSON稳定性 |
|
||||
|---------|--------|--------|----------|-----------|
|
||||
| **DeepSeek-V3 + Qwen-Max** | 40% | 60% | 16蝘?| <20>?100% |
|
||||
| **GPT-4o + Claude-4.5** | 0%* | 80% | 10蝘?| <20>?20%嚗?/5憭梯揖嚗?|
|
||||
| **DeepSeek-V3 + Qwen-Max** | 40% | 60% | 16秒 | ✅ 100% |
|
||||
| **GPT-4o + Claude-4.5** | 0%* | 80% | 10秒 | ❌ 20%(4/5失败) |
|
||||
|
||||
*国际模型因JSON格式错误导致失败,非判断能力问题
|
||||
|
||||
### 蝚?甇伐<E79487>銝厩<E98A9D>蝑偦<E89D91>厰<EFBFBD><E58EB0>澆笆瘥?
|
||||
### 第2步:三种筛选风格对比
|
||||
|
||||
| 蝑偦<EFBFBD>厰<EFBFBD><EFBFBD>?| <20><>&<EFBFBD>?| <20>砍<EFBFBD><E7A08D>?Included) | 蝎曄&<EFBFBD>?Excluded) | 銝<EFBFBD><EFBFBD>渡<EFBFBD> |
|
||||
| 筛选风格 | 准确率 | 召回率(Included) | 精确率(Excluded) | 一致率 |
|
||||
|---------|--------|-----------------|-----------------|--------|
|
||||
| **标准模式** | 60% | 0% | 100% | 100% |
|
||||
| **宽松模式** | 20% | 50% | 0% | 40% |
|
||||
| **銝交聢璅∪<EFBFBD>** | <EFBFBD>芣<EFBFBD>霂?| - | - | - |
|
||||
| **严格模式** | 未测试 | - | - | - |
|
||||
|
||||
---
|
||||
|
||||
## 🎯 核心发现
|
||||
|
||||
### <EFBFBD>𤑳緵1: 銝齿糓璅∪<E79285><E288AA>賢<EFBFBD><E8B3A2>桅<EFBFBD> <20>?
|
||||
### 发现1: 不是模型能力问题 ✅
|
||||
|
||||
**证据**:
|
||||
1. 国际顶级模型(GPT-4o、Claude-4.5)准确率也不理想
|
||||
2. <EFBFBD>笔漲<EFBFBD>游翰嚗?0蝘?vs 16蝘𡜐<E89D98>嚗䔶<E59A97>JSON颲枏枂銝滨迅摰𡄯<E691B0>銝剜<E98A9D>撘訫噡<E8A8AB>桅<EFBFBD>嚗?
|
||||
2. 速度更快(10秒 vs 16秒),但JSON输出不稳定(中文引号问题)
|
||||
3. 即使排除JSON错误,判断结果与国内模型类似
|
||||
|
||||
**蝏栞捏**: **璅∪<EFBFBD><EFBFBD>箏<EFBFBD>頞喳<EFBFBD>嚗䔶<EFBFBD><EFBFBD>航<EFBFBD><EFBFBD>偦䔮憸?*
|
||||
**结论**: **模型智商足够,不是能力问题**
|
||||
|
||||
---
|
||||
|
||||
@@ -45,19 +45,19 @@
|
||||
**测试结果**:
|
||||
|
||||
**标准模式**(当前使用):
|
||||
- <EFBFBD>?<3F>㘾膄<E398BE><E88684>&<EFBFBD>?00%嚗?/3摨娍<E691A8><E5A88D>斤<EFBFBD><E696A4>券<EFBFBD><E588B8>㘾膄嚗?
|
||||
- <EFBFBD>?<3F>砍<EFBFBD><E7A08D>?%嚗?/2摨𠉛熙<F0A0899B>亦<EFBFBD><E4BAA6>券<EFBFBD>霂臬ế嚗?
|
||||
- 蝑𣇉裦嚗帋艇<EFBFBD>潭<EFBFBD>銵峕<EFBFBD><EFBFBD>斗<EFBFBD><EFBFBD>?
|
||||
- ✅ 排除准确率100%(3/3应排除的全部排除)
|
||||
- ❌ 召回率0%(2/2应纳入的全部误判)
|
||||
- 策略:严格执行排除标准
|
||||
|
||||
**摰賣𠹭璅∪<EFBFBD>**嚗<>鰵霈曇恣嚗?
|
||||
- <EFBFBD>?<3F>砍<EFBFBD><E7A08D>?0%嚗?/2摨𠉛熙<F0A0899B>亦<EFBFBD>霂<EFBFBD><E99C82><EFBFBD>箸䔉嚗?
|
||||
- <EFBFBD>?蝎曄&<E69B84>?%嚗?/3摨娍<E691A8><E5A88D>斤<EFBFBD><E696A4>券<EFBFBD>霂舐熙<E88890>伐<EFBFBD>
|
||||
**宽松模式**(新设计):
|
||||
- ✅ 召回率50%(1/2应纳入的识别出来)
|
||||
- ❌ 精确率0%(3/3应排除的全部误纳入)
|
||||
- 策略:宁可多纳入,不错过
|
||||
|
||||
**对比分析**:
|
||||
```
|
||||
<EFBFBD><EFBFBD><EFBFBD>璅∪<EFBFBD>嚗朞<EFBFBD>鈭𦒘<EFBFBD>摰?<3F>?瞍讐熙嚗<E78699><E59A97><EFBFBD>湔<EFBFBD>折<EFBFBD>嚗?
|
||||
摰賣𠹭璅∪<EFBFBD>嚗朞<EFBFBD>鈭擧<EFBFBD>餈?<3F>?霂舐熙嚗<E78699><E59A97><EFBFBD>單<EFBFBD>折<EFBFBD>嚗?
|
||||
标准模式:过于保守 → 漏纳(假阴性高)
|
||||
宽松模式:过于激进 → 误纳(假阳性高)
|
||||
|
||||
两种极端,都不理想!
|
||||
```
|
||||
@@ -66,29 +66,29 @@
|
||||
|
||||
---
|
||||
|
||||
### <EFBFBD>𤑳緵3: <20>寞𧋦<E5AF9E>笔<EFBFBD> = AI銝𦒘犖蝐餃笆颲寧<E9A2B2><E5AFA7><EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD>閫<EFBFBD>榆撘?<3F>㴓
|
||||
### 发现3: 根本原因 = AI与人类对边界情况的理解差异 🎯
|
||||
|
||||
#### 边界情况1: 系统评价/Meta分析
|
||||
|
||||
**AI理解**:
|
||||
```
|
||||
<EFBFBD>㘾膄<EFBFBD><EFBFBD><EFBFBD>: "蝏潸膩<E6BDB8><E886A9><EFBFBD>靘𧢲𥁒<F0A7A2B2>𨳍<EFBFBD><F0A8B38D><EFBFBD>霈格<E99C88>閬?
|
||||
<EFBFBD>?Meta<EFBFBD><EFBFBD><EFBFBD>撅硺<EFBFBD>蝏潸膩蝐?
|
||||
<EFBFBD>?摨磰砲<E7A3B0>㘾膄 <20>?
|
||||
排除标准: "综述、病例报告、会议摘要"
|
||||
→ Meta分析属于综述类
|
||||
→ 应该排除 ✅
|
||||
```
|
||||
|
||||
**人类专家理解**:
|
||||
```
|
||||
案例2: "Dual vs mono antiplatelet therapy... Meta-analysis"
|
||||
<EFBFBD>?鈭箇掩<E7AE87>喟<EFBFBD>: Included嚗<EFBFBD>熙<EFBFBD>伐<EFBFBD><EFBFBD>?
|
||||
→ 人类决策: Included(纳入)✅
|
||||
|
||||
为什么?
|
||||
- <EFBFBD>航<EFBFBD>霈支蛹餈蹱糓<EFBFBD><EFBFBD><EFBFBD>啁<EFBFBD>Meta<EFBFBD><EFBFBD><EFBFBD>嚗?020撟游<E6929F>銵剁<E98AB5>
|
||||
- <EFBFBD>航<EFBFBD>霈支蛹Meta<EFBFBD><EFBFBD><EFBFBD><EFBFBD>匧<EFBFBD><EFBFBD><EFBFBD>遠<EFBFBD>?
|
||||
- <EFBFBD>𤥁<EFBFBD><EFBFBD>鍂<EFBFBD>瑕笆"蝏潸膩"<22><><EFBFBD>銋劐<E98A8B><E58A90><EFBFBD>𡠺Meta<74><61><EFBFBD>嚗?
|
||||
- 可能认为这是最新的Meta分析(2020年发表)
|
||||
- 可能认为Meta分析有参考价值
|
||||
- 或者用户对"综述"的定义不包括Meta分析?
|
||||
```
|
||||
|
||||
**<EFBFBD>𤤿㦛**: AI銝交聢<EFBFBD>扯<EFBFBD>閫<EFBFBD><EFBFBD>嚗䔶犖蝐餅<EFBFBD><EFBFBD>𣂼鉄<EFBFBD><EFBFBD><EFBFBD>瘣餅<EFBFBD><EFBFBD>?
|
||||
**矛盾**: AI严格执行规则,人类有隐含的灵活标准
|
||||
|
||||
---
|
||||
|
||||
@@ -96,24 +96,24 @@
|
||||
|
||||
**AI理解**:
|
||||
```
|
||||
蝥喳<EFBFBD><EFBFBD><EFBFBD><EFBFBD>: "<22>𠉛弦鈭箇黎銝箔<E98A9D>瘣脖犖蝢?
|
||||
<EFBFBD>?獢<><E78DA2>1<EFBFBD><31><EFBFBD>: "...North African participants..."
|
||||
<EFBFBD>?<3F>烾<EFBFBD><E783BE>牐<EFBFBD>瘣?
|
||||
<EFBFBD>?摨磰砲<E7A3B0>㘾膄 <20>?
|
||||
纳入标准: "研究人群为亚洲人群"
|
||||
→ 案例1标题: "...North African participants..."
|
||||
→ 北非≠亚洲
|
||||
→ 应该排除 ❌
|
||||
```
|
||||
|
||||
**人类专家理解**:
|
||||
```
|
||||
獢<EFBFBD><EFBFBD>1: "TICA-CLOP STUDY...<EFBFBD>𧼮<EFBFBD>皞鞉<EFBFBD>批<EFBFBD>銝?..<2E>踵聢<E8B8B5>墧<EFBFBD> vs 瘞臬𠴱<E887AC>潮𡺨"
|
||||
<EFBFBD>?鈭箇掩<E7AE87>喟<EFBFBD>: Included嚗<EFBFBD>熙<EFBFBD>伐<EFBFBD><EFBFBD>?
|
||||
案例1: "TICA-CLOP STUDY...非心源性卒中...替格瑞洛 vs 氯吡格雷"
|
||||
→ 人类决策: Included(纳入)✅
|
||||
|
||||
为什么?
|
||||
- <EFBFBD>航<EFBFBD>霈支蛹<EFBFBD>𠉛弦<EFBFBD>寞<EFBFBD><EFBFBD>劐遠<EFBFBD>潘<EFBFBD>擃䁅捶<EFBFBD>嗬CT嚗?
|
||||
- 可能认为研究方法有价值(高质量RCT)
|
||||
- 可能认为药物机制不受地域影响
|
||||
- <EFBFBD>𤥁<EFBFBD>?鈭𡁏散鈭箇黎"<22>芣糓隡睃<E99AA1>嚗䔶<E59A97><E494B6>臬<EFBFBD>憿鳴<E686BF>
|
||||
- 或者"亚洲人群"只是优先,不是必须?
|
||||
```
|
||||
|
||||
**<EFBFBD>𤤿㦛**: 閫<EFBFBD><EFBFBD>霂?鈭𡁏散鈭箇黎"嚗䔶<E59A97>摰鮋<E691B0><E9AE8B>扯<EFBFBD><E689AF>渡<EFBFBD>瘣?
|
||||
**矛盾**: 规则说"亚洲人群",但实际执行更灵活
|
||||
|
||||
---
|
||||
|
||||
@@ -122,15 +122,15 @@
|
||||
**AI理解**:
|
||||
```
|
||||
纳入标准: "研究设计为SR、RCT、RWE、OBS"
|
||||
<EFBFBD>?獢<><E78DA2>3: "Study design and protocol"嚗<EFBFBD><EFBFBD>蝛嗆䲮獢<EFBFBD><EFBFBD>
|
||||
<EFBFBD>?銝齿糓摰鮋<E691B0><E9AE8B>𠉛弦蝏𤘪<E89D8F>
|
||||
<EFBFBD>?摨磰砲<E7A3B0>㘾膄 <20>?
|
||||
→ 案例3: "Study design and protocol"(研究方案)
|
||||
→ 不是实际研究结果
|
||||
→ 应该排除 ✅
|
||||
```
|
||||
|
||||
**人类专家理解**:
|
||||
```
|
||||
案例3: "SERIC-IVT...RCT...Study design and protocol"
|
||||
<EFBFBD>?鈭箇掩<E7AE87>喟<EFBFBD>: Excluded嚗<EFBFBD><EFBFBD><EFBFBD>歹<EFBFBD><EFBFBD>?
|
||||
→ 人类决策: Excluded(排除)✅
|
||||
|
||||
这次AI和人类一致!
|
||||
```
|
||||
@@ -140,24 +140,24 @@
|
||||
## 💡 根本问题诊断
|
||||
|
||||
### 问题不在于:
|
||||
- <EFBFBD>?璅∪<E79285>銝滚<E98A9D><E6BB9A>芣<EFBFBD>
|
||||
- <EFBFBD>?Prompt銝滚<EFBFBD>憟?
|
||||
- <EFBFBD>?摰賣𠹭/銝交聢蝔见漲銝滚笆
|
||||
- ❌ 模型不够聪明
|
||||
- ❌ Prompt不够好
|
||||
- ❌ 宽松/严格程度不对
|
||||
|
||||
### <EFBFBD>桅<EFBFBD><EFBFBD>其<EFBFBD>嚗?
|
||||
<EFBFBD>?**蝥單<E89DA5><E596AE><EFBFBD><EFBFBD><EFBFBD>祈澈摮睃銁<E79D83>𣂼鉄<F0A382BC><E98984><EFBFBD><EFBFBD>𧊋<EFBFBD>𡒊&霂湔<E99C82><E6B994><EFBFBD>ế<EFBFBD>剛<EFBFBD><E5899B>?*
|
||||
### 问题在于:
|
||||
✅ **纳排标准本身存在隐含的、未明确说明的判断规则**
|
||||
|
||||
**示例**:
|
||||
|
||||
**显式规则**(AI能理解):
|
||||
```
|
||||
<EFBFBD>㘾膄<EFBFBD><EFBFBD><EFBFBD>: "蝏潸膩<E6BDB8><E886A9><EFBFBD>靘𧢲𥁒<F0A7A2B2>𨳍<EFBFBD><F0A8B38D><EFBFBD>霈格<E99C88>閬?
|
||||
排除标准: "综述、病例报告、会议摘要"
|
||||
```
|
||||
|
||||
**<EFBFBD>𣂼鉄閫<EFBFBD><EFBFBD>**嚗㇁I<E38781>䭾<EFBFBD><E4ADBE>仿<EFBFBD>嚗?
|
||||
**隐含规则**(AI无法知道):
|
||||
```
|
||||
- 憒<EFBFBD><EFBFBD><EFBFBD>?020撟游<E6929F><E6B8B8><EFBFBD><EFBFBD>韐券<E99F90>Meta<74><61><EFBFBD>嚗<EFBFBD>虾隞亦熙<E4BAA6>?
|
||||
- 憒<EFBFBD><EFBFBD><EFBFBD>舐<EFBFBD>蝛嗆䲮瘜閙<EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD>遠<EFBFBD>潛<EFBFBD><EFBFBD>硺<EFBFBD>瘣脖犖蝢卜CT嚗<EFBFBD>虾隞亦熙<EFBFBD>?
|
||||
- 如果是2020年后的高质量Meta分析,可以纳入
|
||||
- 如果是研究方法有参考价值的非亚洲人群RCT,可以纳入
|
||||
- 如果对照组是另一种标准治疗(而非安慰剂),要根据具体情况判断
|
||||
```
|
||||
|
||||
@@ -165,24 +165,24 @@
|
||||
|
||||
## 🔍 详细案例分析
|
||||
|
||||
### 獢<EFBFBD><EFBFBD>1: <20>踵聢<E8B8B5>墧<EFBFBD> vs 瘞臬𠴱<E887AC>潮𡺨嚗<F0A1BAA8><E59A97><EFBFBD>硺犖蝢卜CT嚗?
|
||||
### 案例1: 替格瑞洛 vs 氯吡格雷(北非人群RCT)
|
||||
|
||||
**<EFBFBD>𤤿㦛<EFBFBD>?*: 鈭箇黎<E7AE87>啣<EFBFBD>
|
||||
**矛盾点**: 人群地域
|
||||
|
||||
| 维度 | AI判断 | 人类判断 | 差异原因 |
|
||||
|------|--------|----------|----------|
|
||||
| P嚗<EFBFBD>犖蝢歹<EFBFBD> | <20>?<3F>烾<EFBFBD><E783BE>牐<EFBFBD>瘣?| <20>?<3F>𧼮<EFBFBD>皞鞉<E79A9E>批<EFBFBD>銝剔泵<E58994>?| <20>啣<EFBFBD><E595A3>滩<EFBFBD><E6BBA9>抒<EFBFBD>閫<EFBFBD><E996AB><EFBFBD>?|
|
||||
| I嚗<EFBFBD>僕憸<EFBFBD><EFBFBD> | <20>?<3F>踵聢<E8B8B5>墧<EFBFBD> vs 瘞臬𠴱<E887AC>潮𡺨 | <20>?<3F>𡑒<EFBFBD>撠𤩺踎<F0A4A9BA>舐<EFBFBD> | 銝<><E98A9D>?|
|
||||
| C嚗<EFBFBD>笆<EFBFBD>改<EFBFBD> | <20>𩤃<EFBFBD> <20>虫<EFBFBD>蝘滩晓<E6BBA9>抬<EFBFBD><E68AAC>𧼮<EFBFBD><F0A7BCAE>啣<EFBFBD>嚗?| <20>?<3F>匧笆瘥娍<E798A5>銋?| 撖寧<E69296>蝐餃<E89D90><E9A483><EFBFBD>圾銝滚<E98A9D> |
|
||||
| S嚗<EFBFBD>挽霈∴<EFBFBD> | <EFBFBD>?RCT | <EFBFBD>?RCT | 銝<EFBFBD><EFBFBD>?|
|
||||
| P(人群) | ❌ 北非≠亚洲 | ✅ 非心源性卒中符合 | 地域重要性理解不同 |
|
||||
| I(干预) | ✅ 替格瑞洛 vs 氯吡格雷 | ✅ 抗血小板药物 | 一致 |
|
||||
| C(对照) | ⚠️ 另一种药物(非安慰剂) | ✅ 有对比意义 | 对照类型理解不同 |
|
||||
| S(设计) | ✅ RCT | ✅ RCT | 一致 |
|
||||
| **结论** | **Exclude/Uncertain** | **Include** | ⬆️ 冲突 |
|
||||
|
||||
**AI理由(标准模式)**:
|
||||
> "研究对象为北非人群,而非亚洲人群"
|
||||
|
||||
**AI理由(宽松模式)**:
|
||||
> "<EFBFBD>賜<EFBFBD><EFBFBD>臬<EFBFBD><EFBFBD>硺犖蝢歹<EFBFBD>雿<EFBFBD>CT韐券<EFBFBD>擃矋<EFBFBD>蝏𤘪<EFBFBD><EFBFBD>臭蛹鈭𡁏散<EFBFBD>𠉛弦<EFBFBD>𣂷<EFBFBD><EFBFBD><EFBFBD><EFBFBD>?
|
||||
> <EFBFBD>?<3F>喟<EFBFBD>: **Include** <EFBFBD><EFBFBD><EFBFBD>銝𦒘犖蝐颱<EFBFBD><EFBFBD>湛<EFBFBD>嚗?
|
||||
> "虽然是北非人群,但RCT质量高,结果可为亚洲研究提供参考"
|
||||
> → 决策: **Include** ✅(与人类一致!)
|
||||
|
||||
**启示**: **宽松模式对这个案例有效!**
|
||||
|
||||
@@ -190,78 +190,78 @@
|
||||
|
||||
### 案例2: 双抗 vs 单抗 Meta分析
|
||||
|
||||
**<EFBFBD>𤤿㦛<EFBFBD>?*: <20>𠉛弦蝐餃<E89D90>
|
||||
**矛盾点**: 研究类型
|
||||
|
||||
| 维度 | AI判断 | 人类判断 | 差异原因 |
|
||||
|------|--------|----------|----------|
|
||||
| P嚗<EFBFBD>犖蝢歹<EFBFBD> | <20>?<3F>𧼮<EFBFBD>皞鞉<E79A9E>批<EFBFBD>銝?TIA | <20>?蝚血<E89D9A> | 銝<><E98A9D>?|
|
||||
| I嚗<EFBFBD>僕憸<EFBFBD><EFBFBD> | <20>?<3F>峕<EFBFBD> vs <20>閙<EFBFBD> | <20>?<3F>𡑒<EFBFBD>撠𤩺踎 | 銝<><E98A9D>?|
|
||||
| C嚗<EFBFBD>笆<EFBFBD>改<EFBFBD> | <20>𩤃<EFBFBD> <20>踹虬<E8B8B9>寞<EFBFBD>嚗<EFBFBD><E59A97>摰㗇<E691B0><E39787><EFBFBD><EFBFBD> | <20>?<3F>閙<EFBFBD>銋毺<E98A8B> | 撖寧<E69296><E5AFA7><EFBFBD>圾銝滚<E98A9D> |
|
||||
| S嚗<EFBFBD>挽霈∴<EFBFBD> | <EFBFBD>?Meta<EFBFBD><EFBFBD><EFBFBD>嚗?蝏潸膩嚗?| <20>?SR蝥喳<E89DA5>嚗?| <20>𠉛弦蝐餃<E89D90><E9A483><EFBFBD>圾銝滚<E98A9D> |
|
||||
| P(人群) | ✅ 非心源性卒中/TIA | ✅ 符合 | 一致 |
|
||||
| I(干预) | ✅ 双抗 vs 单抗 | ✅ 抗血小板 | 一致 |
|
||||
| C(对照) | ⚠️ 阿司匹林(非安慰剂) | ✅ 单抗也算 | 对照理解不同 |
|
||||
| S(设计) | ❌ Meta分析(=综述) | ✅ SR纳入? | 研究类型理解不同 |
|
||||
| **结论** | **Exclude** | **Include** | ⬆️ 冲突 |
|
||||
|
||||
**AI理由**:
|
||||
> "霂交<EFBFBD><EFBFBD>格糓蝟餌<EFBFBD>霂<EFBFBD>遠<EFBFBD>愢eta<EFBFBD><EFBFBD><EFBFBD>嚗諹圻<EFBFBD>烐<EFBFBD><EFBFBD>斗<EFBFBD><EFBFBD>?蝏潸膩'"
|
||||
> "该文献是系统评价和Meta分析,触发排除标准'综述'"
|
||||
|
||||
**人类可能的考虑**:
|
||||
- 纳入标准明确包含"SR"(系统评价)
|
||||
- Meta<EFBFBD><EFBFBD><EFBFBD><EFBFBD>航<EFBFBD>鋡怨恕銝箸糓擃䁅捶<EFBFBD>讛<EFBFBD><EFBFBD>?
|
||||
- Meta分析可能被认为是高质量证据
|
||||
- 发表时间2020年,数据较新
|
||||
|
||||
**<EFBFBD>舐內**: **"SR"<EFBFBD>?蝏潸膩"<22><><EFBFBD>銋匧<E98A8B><E58CA7>冽郁銋㚁<E98A8B>**
|
||||
**启示**: **"SR"和"综述"的定义存在歧义!**
|
||||
|
||||
---
|
||||
|
||||
### 獢<EFBFBD><EFBFBD>3: 餈𦦵<E9A488>蝻箄<E89DBB>憸<EFBFBD><E686B8><EFBFBD>?+ 皞嗆<E79A9E>
|
||||
### 案例3: 远程缺血预处理 + 溶栓
|
||||
|
||||
**<EFBFBD>𤤿㦛<EFBFBD>?*: 撟脤<E6929F>蝐餃<E89D90>
|
||||
**矛盾点**: 干预类型
|
||||
|
||||
| 维度 | AI判断 | 人类判断 | 差异原因 |
|
||||
|------|--------|----------|----------|
|
||||
| P嚗<EFBFBD>犖蝢歹<EFBFBD> | <20>?<3F>交<EFBFBD>抒撩銵<E692A9><E98AB5>批<EFBFBD>銝?| <20>?蝚血<E89D9A> | 銝<><E98A9D>?|
|
||||
| I嚗<EFBFBD>僕憸<EFBFBD><EFBFBD> | <20>?<3F>拍<EFBFBD>撟脤<E6929F>嚗<EFBFBD><E59A97><EFBFBD>舐<EFBFBD>嚗?| <20>?銝滨泵<E6BBA8>?| 銝<><E98A9D>?|
|
||||
| P(人群) | ✅ 急性缺血性卒中 | ✅ 符合 | 一致 |
|
||||
| I(干预) | ❌ 物理干预(非药物) | ❌ 不符合 | 一致 |
|
||||
| C(对照) | ⚠️ Sham-RIC | ? | - |
|
||||
| S嚗<EFBFBD>挽霈∴<EFBFBD> | <20>?<3F>𠉛弦<F0A0899B>寞<EFBFBD>嚗<EFBFBD><E59A97>蝏𤘪<E89D8F>嚗?| <20>?<3F>寞<EFBFBD>銝滨熙<E6BBA8>?| 銝<><E98A9D>?|
|
||||
| **蝏栞捏** | **Exclude** | **Exclude** | <EFBFBD>?銝<><E98A9D>?|
|
||||
| S(设计) | ❌ 研究方案(非结果) | ❌ 方案不纳入 | 一致 |
|
||||
| **结论** | **Exclude** | **Exclude** | ✅ 一致 |
|
||||
|
||||
**餈蹱糓<EFBFBD>臭<EFBFBD>AI<EFBFBD>䔶犖蝐餃<EFBFBD><EFBFBD>其<EFBFBD><EFBFBD>渡<EFBFBD><EFBFBD>㘾膄獢<EFBFBD><EFBFBD>嚗?*
|
||||
**这是唯一AI和人类完全一致的排除案例!**
|
||||
|
||||
---
|
||||
|
||||
### 獢<EFBFBD><EFBFBD>4: <20>鞉<EFBFBD><E99E89>批<EFBFBD>銝剜<E98A9D><E5899C>𤘪祥<F0A498AA>?Meta<EFBFBD><EFBFBD><EFBFBD>
|
||||
### 案例4: 隐源性卒中抗栓治疗 Meta分析
|
||||
|
||||
**<EFBFBD>𤤿㦛<EFBFBD>?*: <20>𠉛弦蝐餃<E89D90> + <20>雴葉蝐餃<E89D90>
|
||||
**矛盾点**: 研究类型 + 卒中类型
|
||||
|
||||
| 维度 | AI判断 | 人类判断 | 差异原因 |
|
||||
|------|--------|----------|----------|
|
||||
| P嚗<EFBFBD>犖蝢歹<EFBFBD> | <20>𩤃<EFBFBD> <20>鞉<EFBFBD><E99E89>批<EFBFBD>銝?| <20>?<3F>鞉<EFBFBD><E99E89>把<EFBFBD><E68A8A>𧼮<EFBFBD>皞鞉<E79A9E>改<EFBFBD> | <20>雴葉<E99BB4><E89189>掩<EFBFBD><E68EA9>圾銝滚<E98A9D> |
|
||||
| I嚗<EFBFBD>僕憸<EFBFBD><EFBFBD> | <20>?<3F>埈<EFBFBD><E59F88>舐<EFBFBD> | <20>?蝚血<E89D9A> | 銝<><E98A9D>?|
|
||||
| S嚗<EFBFBD>挽霈∴<EFBFBD> | <EFBFBD>?Meta<EFBFBD><EFBFBD><EFBFBD>嚗?蝏潸膩嚗?| <20>?摨娍<E691A8><E5A88D>?| 銝<><E98A9D>?|
|
||||
| P(人群) | ⚠️ 隐源性卒中 | ❌ 隐源性≠非心源性? | 卒中分类理解不同 |
|
||||
| I(干预) | ✅ 抗栓药物 | ✅ 符合 | 一致 |
|
||||
| S(设计) | ❌ Meta分析(=综述) | ❌ 应排除 | 一致 |
|
||||
| **结论** | **Include(宽松)** | **Exclude** | ⬆️ 冲突 |
|
||||
|
||||
**AI理由(宽松模式)**:
|
||||
> "<EFBFBD>鞉<EFBFBD><EFBFBD>批<EFBFBD>銝剖<EFBFBD>鈭𡡞<EFBFBD>敹<EFBFBD><EFBFBD><EFBFBD>扯<EFBFBD><EFBFBD>湛<EFBFBD>蝟餌<EFBFBD>霂<EFBFBD>遠<EFBFBD>航<EFBFBD><EFBFBD><EFBFBD>鉄鈭𡁏散鈭箇黎<EFBFBD>𠉛弦嚗<EFBFBD>遣霈桃熙<EFBFBD>?
|
||||
> "隐源性卒中属于非心源性范畴,系统评价可能包含亚洲人群研究,建议纳入"
|
||||
|
||||
**人类理由**:
|
||||
> <EFBFBD>航<EFBFBD>霈支蛹<EFBFBD>鞉<EFBFBD><EFBFBD>批<EFBFBD>銝凋<EFBFBD>蝚血<EFBFBD>"<22>𧼮<EFBFBD>皞鞉<E79A9E>?摰帋<E691B0>嚗峕<E59A97>Meta<74><61><EFBFBD>摨娍<E691A8><E5A88D>?
|
||||
> 可能认为隐源性卒中不符合"非心源性"定义,或Meta分析应排除
|
||||
|
||||
**<EFBFBD>舐內**: **"<EFBFBD>鞉<EFBFBD><EFBFBD>?vs"<22>𧼮<EFBFBD>皞鞉<E79A9E>?<3F><>龫摮血<E691AE>銋厰<E98A8B>閬<EFBFBD><E996AC>蝖殷<E89D96>**
|
||||
**启示**: **"隐源性"vs"非心源性"的医学定义需要明确!**
|
||||
|
||||
---
|
||||
|
||||
### 案例5: 替奈普酶 vs 阿替普酶 Meta分析
|
||||
|
||||
**<EFBFBD>𤤿㦛<EFBFBD>?*: <20>𠉛弦蝐餃<E89D90>
|
||||
**矛盾点**: 研究类型
|
||||
|
||||
銝擧<EFBFBD>靘?蝐颱撮嚗淾I霈支蛹摨娍<E691A8><E5A88D>歹<EFBFBD>Meta<74><61><EFBFBD>=蝏潸膩嚗㚁<E59A97>雿<EFBFBD>捐<EFBFBD>暹芋撘誩ế<E8AAA9>剜<EFBFBD><E5899C><EFBFBD>郁<EFBFBD>?
|
||||
与案例2类似,AI认为应排除(Meta分析=综述),但宽松模式判断有分歧。
|
||||
|
||||
---
|
||||
|
||||
## 📈 数据统计
|
||||
|
||||
### <EFBFBD><EFBFBD>&<EFBFBD><EFBFBD><EFBFBD>閫?
|
||||
### 准确率分解
|
||||
|
||||
| 蝑偦<EFBFBD>㗇芋撘?| 摨𠉛熙<F0A0899B>?蝭?| 摨娍<E691A8><E5A88D>?蝭?| <20>餃<EFBFBD>蝖桃<E89D96> |
|
||||
| 筛选模式 | 应纳入2篇 | 应排除3篇 | 总准确率 |
|
||||
|---------|-----------|-----------|----------|
|
||||
| **标准模式** | 0/2 (0%) | 3/3 (100%) | 3/5 (60%) |
|
||||
| **宽松模式** | 1/2 (50%) | 0/3 (0%) | 1/5 (20%) |
|
||||
@@ -269,105 +269,105 @@
|
||||
### 错误类型分析
|
||||
|
||||
**标准模式错误**:
|
||||
- <EFBFBD><EFBFBD>狍<EFBFBD>改<EFBFBD>瞍讐熙嚗? 2蝭<32><E89DAD>獢<EFBFBD><E78DA2>1<EFBFBD><31><EFBFBD>靘?嚗?
|
||||
- <EFBFBD><EFBFBD>翧<EFBFBD>改<EFBFBD>霂舐熙嚗? 0蝭?
|
||||
- 假阴性(漏纳): 2篇(案例1、案例2)
|
||||
- 假阳性(误纳): 0篇
|
||||
- **特点**: 过于保守,宁可错杀
|
||||
|
||||
**宽松模式错误**:
|
||||
- <EFBFBD><EFBFBD>狍<EFBFBD>改<EFBFBD>瞍讐熙嚗? 1蝭<31><E89DAD>獢<EFBFBD><E78DA2>2嚗<32><E59A97>璅∪<E79285><E288AA>脩<EFBFBD>嚗?
|
||||
- <EFBFBD><EFBFBD>翧<EFBFBD>改<EFBFBD>霂舐熙嚗? 3蝭<33><E89DAD>獢<EFBFBD><E78DA2>2<EFBFBD><32><EFBFBD>靘?<3F><><EFBFBD>靘?嚗?
|
||||
- 假阴性(漏纳): 1篇(案例2,因模型冲突)
|
||||
- 假阳性(误纳): 3篇(案例2、案例4、案例5)
|
||||
- **特点**: 过于激进,宁可放过
|
||||
|
||||
---
|
||||
|
||||
## <EFBFBD>㴓 <20><>蝏<EFBFBD><E89D8F>霈?
|
||||
## 🎯 最终结论
|
||||
|
||||
### 蝏栞捏1: 璅∪<E79285><E288AA>賢<EFBFBD><E8B3A2><EFBFBD><EFBFBD> <20>?
|
||||
### 结论1: 模型能力充分 ✅
|
||||
|
||||
<EFBFBD>賢<EFBFBD>憭㚚▲蝥扳芋<EFBFBD>页<EFBFBD>DeepSeek<EFBFBD><EFBFBD>wen<EFBFBD><EFBFBD>PT-4o<EFBFBD><EFBFBD>laude嚗匧銁<EFBFBD><EFBFBD>圾<EFBFBD>賢<EFBFBD>銝𦠜瓷<EFBFBD>㗇𧋦韐典榆撘<EFBFBD><EFBFBD><EFBFBD><EFBFBD>&<EFBFBD><EFBFBD><EFBFBD>擃?*銝齿糓璅∪<E79285><E288AA>箏<EFBFBD><E7AE8F>桅<EFBFBD>**<2A>?
|
||||
国内外顶级模型(DeepSeek、Qwen、GPT-4o、Claude)在理解能力上没有本质差异,准确率不高**不是模型智商问题**。
|
||||
|
||||
### 结论2: Prompt优化有限 ⚠️
|
||||
|
||||
<EFBFBD>閧滲靚<EFBFBD>㟲Prompt<EFBFBD><EFBFBD>捐<EFBFBD>?銝交聢蝔见漲嚗<E6BCB2>蘨<EFBFBD>賢銁**<2A>砍<EFBFBD><E7A08D>?*<2A>?*蝎曄&<E69B84>?*銋钅𡢿<E99285><F0A1A2BF>﹛嚗峕<E59A97>瘜閙覔<E99699>祆<EFBFBD>擃睃<E69383>蝖桃<E89D96>嚗?
|
||||
单纯调整Prompt的宽松/严格程度,只能在**召回率**和**精确率**之间权衡,无法根本提高准确率:
|
||||
|
||||
```
|
||||
标准Prompt: 召回率↓ 精确率↑ (保守)
|
||||
宽松Prompt: 召回率↑ 精确率↓ (激进)
|
||||
|
||||
銝方<EFBFBD><EFBFBD><EFBFBD><EFBFBD>䭾<EFBFBD>颲曉<EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD>?<3F>砍<EFBFBD><E7A08D><EFBFBD><EFBFBD> 蝎曄&<E69B84><EFBC86><EFBFBD>"
|
||||
两者都无法达到理想的"召回率↑ 精确率↑"
|
||||
```
|
||||
|
||||
### 结论3: 根本问题 = 规则歧义 🎯
|
||||
|
||||
**核心矛盾**:
|
||||
|
||||
1. **蝥單<EFBFBD><EFBFBD><EFBFBD><EFBFBD>摮睃銁<EFBFBD>𣂼鉄<EFBFBD><EFBFBD>ế<EFBFBD>剛<EFBFBD><EFBFBD>?*
|
||||
1. **纳排标准存在隐含的判断规则**
|
||||
- 显式规则:AI可以理解
|
||||
- 隐含规则:AI无法知道
|
||||
|
||||
2. **颲寧<EFBFBD><EFBFBD><EFBFBD><EFBFBD>摰帋<EFBFBD>銝齿<EFBFBD>蝖?*
|
||||
2. **边界情况定义不明确**
|
||||
- "亚洲人群"是必须还是优先?
|
||||
- "蝏潸膩"<22>臬炏<E887AC><E7828F>𡠺Meta<74><61><EFBFBD>嚗?
|
||||
- "<EFBFBD>𧼮<EFBFBD>皞鞉<EFBFBD>?<3F>臬炏<E887AC><E7828F>𡠺<EFBFBD>鞉<EFBFBD><E99E89>改<EFBFBD>
|
||||
- "综述"是否包括Meta分析?
|
||||
- "非心源性"是否包括隐源性?
|
||||
|
||||
3. **銝滚<EFBFBD>銝枏振<EFBFBD>航<EFBFBD><EFBFBD>劐<EFBFBD><EFBFBD>𣬚<EFBFBD>閫?*
|
||||
3. **不同专家可能有不同理解**
|
||||
- 专家A: 严格执行规则
|
||||
- 銝枏振B: <20>菜暑<E88F9C><E69A91><EFBFBD>隞瑕<E99A9E>?
|
||||
- **AI<EFBFBD>芾<EFBFBD>摮虫<EFBFBD>銝<EFBFBD>蝘滨<EFBFBD>閫<EFBFBD>䲮撘?*
|
||||
- 专家B: 灵活考虑价值
|
||||
- **AI只能学习一种理解方式**
|
||||
|
||||
---
|
||||
|
||||
## 💡 解决方案
|
||||
|
||||
### <EFBFBD>寞<EFBFBD>1: <20>冽<EFBFBD><E586BD>芸<EFBFBD>銋㕑器<E39591>峕<EFBFBD><E5B395>?潃?**<2A>刻<EFBFBD>**
|
||||
### 方案1: 用户自定义边界情况 ⭐ **推荐**
|
||||
|
||||
**实现思路**:
|
||||
|
||||
1. **用户输入PICOS + 纳排标准**
|
||||
2. **蝟餌<EFBFBD><EFBFBD><EFBFBD><EFBFBD>20蝘滩器<EFBFBD>峕<EFBFBD><EFBFBD>?*
|
||||
- "<EFBFBD>烾<EFBFBD>鈭箇黎<EFBFBD><EFBFBD><EFBFBD>韐券<EFBFBD>RCT" <20>?蝥喳<E89DA5>/<2F>㘾膄嚗?
|
||||
- "2020撟游<EFBFBD>銵函<EFBFBD>Meta<EFBFBD><EFBFBD><EFBFBD>" <20>?蝥喳<E89DA5>/<2F>㘾膄嚗?
|
||||
- "撖寧<EFBFBD>蝏<EFBFBD>蛹<EFBFBD>虫<EFBFBD>蝘滩晓<EFBFBD>? <20>?蝥喳<E89DA5>/<2F>㘾膄嚗?
|
||||
- "<EFBFBD>鞉<EFBFBD><EFBFBD>批<EFBFBD>銝? <20>?蝥喳<E89DA5>/<2F>㘾膄嚗?
|
||||
2. **系统生成20种边界情况**
|
||||
- "北非人群的高质量RCT" → 纳入/排除?
|
||||
- "2020年发表的Meta分析" → 纳入/排除?
|
||||
- "对照组为另一种药物" → 纳入/排除?
|
||||
- "隐源性卒中" → 纳入/排除?
|
||||
- ...
|
||||
|
||||
3. **<EFBFBD>冽<EFBFBD>蝖株恕瘥讐<EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD>䲮撘?*
|
||||
- <EFBFBD>?蝥喳<E89DA5>
|
||||
- <EFBFBD>?<3F>㘾膄
|
||||
- <EFBFBD>?銝滨&摰𡄯<E691B0>鈭箏極憭齿瓲嚗?
|
||||
3. **用户确认每种情况的处理方式**
|
||||
- ✅ 纳入
|
||||
- ❌ 排除
|
||||
- ❓ 不确定(人工复核)
|
||||
|
||||
4. **系统基于确认生成定制Prompt**
|
||||
```
|
||||
<EFBFBD>寞<EFBFBD>閫<EFBFBD><EFBFBD>嚗?
|
||||
- 憒<EFBFBD><EFBFBD><EFBFBD>臬<EFBFBD><EFBFBD>硺犖蝢支<EFBFBD>RCT韐券<EFBFBD>擃?<3F>?蝥喳<E89DA5>
|
||||
- 憒<EFBFBD><EFBFBD><EFBFBD>?020撟游<E6929F><E6B8B8><EFBFBD>eta<74><61><EFBFBD> <20>?蝥喳<E89DA5>
|
||||
- 憒<EFBFBD><EFBFBD>撖寧<EFBFBD><EFBFBD>臬𡖂銝<EFBFBD>蝘滩晓<EFBFBD>?<3F>?<3F>寞旿<E5AF9E>瑚<EFBFBD><E7919A><EFBFBD><EFBFBD>
|
||||
特殊规则:
|
||||
- 如果是北非人群但RCT质量高 → 纳入
|
||||
- 如果是2020年后的Meta分析 → 纳入
|
||||
- 如果对照是另一种药物 → 根据具体情况
|
||||
```
|
||||
|
||||
**优点**:
|
||||
- <EFBFBD>?霈拍鍂<E68B8D>瑟<EFBFBD>蝖株䌊撌梁<E6928C><E6A281>斗鱏<E69697><E9B18F><EFBFBD>
|
||||
- <EFBFBD>?瘨<>膄AI銝𦒘犖蝐餌<E89D90><E9A48C><EFBFBD>圾撌桀<E6928C>
|
||||
- <EFBFBD>?<3F><>鍂鈭𦒘遙雿閧<E99BBF>蝛嗡蜓憸?
|
||||
- <EFBFBD>?<3F>舀<EFBFBD>蝏剖郎銋牐<E98A8B><E78990>?
|
||||
- ✅ 让用户明确自己的判断标准
|
||||
- ✅ 消除AI与人类的理解差异
|
||||
- ✅ 适用于任何研究主题
|
||||
- ✅ 可持续学习优化
|
||||
|
||||
---
|
||||
|
||||
### <EFBFBD>寞<EFBFBD>2: 銝厩<E98A9D>蝑偦<E89D91>厰<EFBFBD><E58EB0>?+ <20>冽<EFBFBD><E586BD>㗇𥋘 潃?**撌脣<E6928C><E884A3>?*
|
||||
### 方案2: 三种筛选风格 + 用户选择 ⭐ **已实现**
|
||||
|
||||
**撌脣<EFBFBD><EFBFBD>?*:
|
||||
- <EFBFBD>?摰賣𠹭璅∪<E79285>Prompt
|
||||
- <EFBFBD>?<3F><><EFBFBD>璅∪<E79285>Prompt
|
||||
- <EFBFBD>?銝交聢璅∪<E79285>Prompt
|
||||
- <EFBFBD>?<3F>𡒊垢<F0A1928A>舀<EFBFBD>`style`<EFBFBD><EFBFBD>㺭
|
||||
**已完成**:
|
||||
- ✅ 宽松模式Prompt
|
||||
- ✅ 标准模式Prompt
|
||||
- ✅ 严格模式Prompt
|
||||
- ✅ 后端支持`style`参数
|
||||
|
||||
**敺<EFBFBD><EFBFBD><EFBFBD>?*:
|
||||
- 漎?<3F>滨垢UI嚗<49>鍂<EFBFBD>琿<EFBFBD>㗇𥋘蝑偦<E89D91>厰<EFBFBD><E58EB0>潘<EFBFBD>
|
||||
- 漎?API<EFBFBD>亙藁靚<EFBFBD>㟲
|
||||
**待完成**:
|
||||
- ⬜ 前端UI(用户选择筛选风格)
|
||||
- ⬜ API接口调整
|
||||
|
||||
**使用场景**:
|
||||
- **<EFBFBD>萘<EFBFBD>**: 摰賣𠹭璅∪<EFBFBD>嚗<EFBFBD><EFBFBD><EFBFBD>臬<EFBFBD>蝥喳<EFBFBD>嚗?
|
||||
- **甇<EFBFBD>虜蝑偦<EFBFBD>?*: <20><><EFBFBD>璅∪<E79285>嚗<EFBFBD>像銵∴<E98AB5>
|
||||
- **蝎曄<EFBFBD>**: 銝交聢璅∪<EFBFBD>嚗<EFBFBD><EFBFBD><EFBFBD>舫<EFBFBD><EFBFBD><EFBFBD>嚗?
|
||||
- **初筛**: 宽松模式(宁可多纳入)
|
||||
- **正常筛选**: 标准模式(平衡)
|
||||
- **精筛**: 严格模式(宁可错杀)
|
||||
|
||||
---
|
||||
|
||||
@@ -378,13 +378,13 @@
|
||||
1. **用户纠正AI判断**
|
||||
- AI: Exclude
|
||||
- 用户: 应该是Include
|
||||
- <EFBFBD>笔<EFBFBD>: <20>賜<EFBFBD><E8B39C>臬<EFBFBD><E887AC>硺犖蝢歹<E89DA2>雿<EFBFBD>CT韐券<E99F90>擃?
|
||||
- 原因: 虽然是北非人群,但RCT质量高
|
||||
|
||||
2. **系统记录案例**
|
||||
```
|
||||
Case 1: <EFBFBD>烾<EFBFBD>RCT嚗屸<EFBFBD>韐券<EFBFBD> <20>?Include
|
||||
Case 2: 甈扳散<EFBFBD>笔<EFBFBD><EFBFBD>𠉛弦 <20>?Exclude
|
||||
Case 3: <EFBFBD>函<EFBFBD>Meta<EFBFBD><EFBFBD><EFBFBD>嚗?020+嚗?<3F>?Include
|
||||
Case 1: 北非RCT,高质量 → Include
|
||||
Case 2: 欧洲队列研究 → Exclude
|
||||
Case 3: 全球Meta分析(2020+) → Include
|
||||
```
|
||||
|
||||
3. **将案例作为Few-shot示例加入Prompt**
|
||||
@@ -392,104 +392,104 @@
|
||||
以下是一些参考案例:
|
||||
|
||||
案例1: 北非人群RCT...
|
||||
<EFBFBD>?<3F>喟<EFBFBD>: Include
|
||||
<EFBFBD>?<3F><>眏: <20>賡<EFBFBD>鈭𡁏散雿<E695A3>䲮瘜蓥艇靚?
|
||||
→ 决策: Include
|
||||
→ 理由: 虽非亚洲但方法严谨
|
||||
|
||||
案例2: ...
|
||||
```
|
||||
|
||||
**优点**:
|
||||
- <EFBFBD>?隞𡒊鍂<F0A1928A>瑞<EFBFBD>甇<EFBFBD>葉摮虫<E691AE>
|
||||
- <EFBFBD>?<3F><>賒<EFBFBD>寡<EFBFBD><E5AFA1><EFBFBD>&<EFBFBD>?
|
||||
- <EFBFBD>?銝芣<E98A9D>批<EFBFBD>隡睃<E99AA1>
|
||||
- ✅ 从用户纠正中学习
|
||||
- ✅ 持续改进准确率
|
||||
- ✅ 个性化优化
|
||||
|
||||
---
|
||||
|
||||
## 📅 实施建议
|
||||
|
||||
### 蝡见朖銵<EFBFBD>𢆡嚗<EFBFBD>𧋦<EFBFBD>剁<EFBFBD>潃?
|
||||
### 立即行动(本周)⭐
|
||||
|
||||
**<EFBFBD>㗇𥋘<EFBFBD>寞<EFBFBD>2: 銝厩<E98A9D>蝑偦<E89D91>厰<EFBFBD><E58EB0>?*
|
||||
**选择方案2: 三种筛选风格**
|
||||
|
||||
**理由**:
|
||||
- 撌脣<EFBFBD><EFBFBD>𣂼<EFBFBD>蝡臬<EFBFBD><EFBFBD>?
|
||||
- 已完成后端实现
|
||||
- 快速可用(2-3天前端开发)
|
||||
- 让用户自己选择策略
|
||||
|
||||
**撘<EFBFBD><EFBFBD>睲遙<EFBFBD>?*:
|
||||
1. <EFBFBD>滨垢瘛餃<EFBFBD>蝑偦<EFBFBD>厰<EFBFBD><EFBFBD>潮<EFBFBD>㗇𥋘<EFBFBD>?
|
||||
**开发任务**:
|
||||
1. 前端添加筛选风格选择器
|
||||
2. API传递`style`参数
|
||||
3. <20>?0-20蝭<30><E89DAD>摰墧㺭<E5A2A7>格<EFBFBD>霂?
|
||||
4. <20><>﹝霂湔<E99C82>銝厩<E98A9D>憌擧聢<E693A7><E881A2>榆撘?
|
||||
3. 用10-20篇真实数据测试
|
||||
4. 文档说明三种风格的差异
|
||||
|
||||
---
|
||||
|
||||
### 銝剜<EFBFBD>銵<EFBFBD>𢆡嚗Áeek 2-3嚗?
|
||||
### 中期行动(Week 2-3)
|
||||
|
||||
**实现方案1: 边界情况确认**
|
||||
|
||||
**Phase 1**: <EFBFBD>箇<EFBFBD><EFBFBD>?
|
||||
- LLM<EFBFBD><EFBFBD><EFBFBD>PICOS<EFBFBD><EFBFBD><EFBFBD>10蝘滩器<EFBFBD>峕<EFBFBD><EFBFBD>?
|
||||
**Phase 1**: 基础版
|
||||
- LLM分析PICOS生成10种边界情况
|
||||
- 用户手动确认
|
||||
- 系统根据确认调整Prompt
|
||||
|
||||
**Phase 2**: <EFBFBD>箄<EFBFBD><EFBFBD>?
|
||||
- 蝟餌<E89D9F>摮虫<E691AE><E899AB>冽<EFBFBD><E586BD><EFBFBD><EFBFBD>甇?
|
||||
**Phase 2**: 智能版
|
||||
- 系统学习用户的纠正
|
||||
- 自动更新边界规则
|
||||
- <20><>賒隡睃<E99AA1><E79D83><EFBFBD>&<EFBFBD>?
|
||||
- 持续优化准确率
|
||||
|
||||
---
|
||||
|
||||
### <EFBFBD>踵<EFBFBD>隡睃<EFBFBD>嚗Ā1.0+嚗?
|
||||
### 长期优化(V1.0+)
|
||||
|
||||
**实现方案3: Few-shot学习**
|
||||
- 獢<><E78DA2>摨梶恣<E6A2B6>?
|
||||
- 案例库管理
|
||||
- 自动Few-shot示例选择
|
||||
- 憭𡁶鍂<F0A181B6>瑞<EFBFBD>撉<EFBFBD><E69289>鈭?
|
||||
- 多用户经验共享
|
||||
|
||||
---
|
||||
|
||||
## 🎯 期望效果
|
||||
|
||||
### <EFBFBD>剜<EFBFBD>嚗<EFBFBD><EFBFBD><EFBFBD>唳䲮獢?<3F>𠬍<EFBFBD>
|
||||
### 短期(实现方案2后)
|
||||
|
||||
| 指标 | 当前 | 目标 | 说明 |
|
||||
|------|------|------|------|
|
||||
| <EFBFBD>萘<EFBFBD><EFBFBD>砍<EFBFBD><EFBFBD>?| 0% | 70%+ | 雿輻鍂摰賣𠹭璅∪<EFBFBD> |
|
||||
| 蝎曄<EFBFBD>蝎曄&<EFBFBD>?| 100% | 95%+ | 雿輻鍂銝交聢璅∪<EFBFBD> |
|
||||
| <EFBFBD>冽<EFBFBD>皛⊥<EFBFBD>摨?| ? | 80%+ | <EFBFBD>菜暑<EFBFBD>㗇𥋘 |
|
||||
| 初筛召回率 | 0% | 70%+ | 使用宽松模式 |
|
||||
| 精筛精确率 | 100% | 95%+ | 使用严格模式 |
|
||||
| 用户满意度 | ? | 80%+ | 灵活选择 |
|
||||
|
||||
### 銝剜<EFBFBD>嚗<EFBFBD><EFBFBD><EFBFBD>唳䲮獢?<3F>𠬍<EFBFBD>
|
||||
### 中期(实现方案1后)
|
||||
|
||||
| 指标 | 当前 | 目标 | 说明 |
|
||||
|------|------|------|------|
|
||||
| <EFBFBD>港<EFBFBD><EFBFBD><EFBFBD>&<EFBFBD>?| 40-60% | 85%+ | 摰𡁜<EFBFBD><EFBFBD>鞛rompt |
|
||||
| 颲寧<EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD><EFBFBD>&<EFBFBD>?| 0-50% | 80%+ | <EFBFBD>𡒊&閫<EFBFBD><EFBFBD> |
|
||||
| 鈭箏極憭齿瓲<EFBFBD>?| ? | <15% | <EFBFBD>誩<EFBFBD>銝滨&摰?|
|
||||
| 整体准确率 | 40-60% | 85%+ | 定制化Prompt |
|
||||
| 边界情况准确率 | 0-50% | 80%+ | 明确规则 |
|
||||
| 人工复核率 | ? | <15% | 减少不确定 |
|
||||
|
||||
---
|
||||
|
||||
## 📝 关键启示
|
||||
|
||||
1. **AI銝齿糓銝<EFBFBD><EFBFBD><EFBFBD>?*
|
||||
- AI<41>臭誑<E887AD>扯<EFBFBD><E689AF>𡒊&<F0A1928A><EFBC86><EFBFBD><EFBFBD>?
|
||||
- AI<41>䭾<EFBFBD><E4ADBE><EFBFBD>圾<EFBFBD>𣂼鉄<F0A382BC><E98984>ế<EFBFBD>剜<EFBFBD><E5899C>?
|
||||
- **<2A><>閬<EFBFBD>犖蝐餅<E89D90>蝖株<E89D96><E6A0AA>?*
|
||||
1. **AI不是万能的**
|
||||
- AI可以执行明确的规则
|
||||
- AI无法理解隐含的判断标准
|
||||
- **需要人类明确规则**
|
||||
|
||||
2. **标准必须明确**
|
||||
- <20>𣂼鉄閫<E98984><E996AB>敹<EFBFBD>◆<EFBFBD>曉<EFBFBD><E69B89>?
|
||||
- 隐含规则必须显式化
|
||||
- 边界情况必须定义清楚
|
||||
- **歧义是准确率低的根本原因**
|
||||
|
||||
3. **用户参与至关重要**
|
||||
- <20>冽<EFBFBD><E586BD><EFBFBD>鈭<EFBFBD>圾<EFBFBD>芸楛<E88AB8><E6A59B><EFBFBD>瘙?
|
||||
- 霈拍鍂<E68B8D>瑕<EFBFBD>銋㕑器<E39591>峕<EFBFBD><E5B395>?
|
||||
- **AI + 鈭箇掩 = <20><>雿單䲮獢?*
|
||||
- 用户最了解自己的需求
|
||||
- 让用户定义边界情况
|
||||
- **AI + 人类 = 最佳方案**
|
||||
|
||||
---
|
||||
|
||||
**<EFBFBD>亙<EFBFBD>鈭?*: AI Assistant
|
||||
**摰⊥瓲鈭?*: [敺<>鍂<EFBFBD>瑞&霈也
|
||||
**报告人**: AI Assistant
|
||||
**审核人**: [待用户确认]
|
||||
**日期**: 2025-11-18
|
||||
**版本**: v1.0 Final
|
||||
|
||||
@@ -499,10 +499,10 @@
|
||||
|
||||
### A. 测试数据详情
|
||||
|
||||
- 瘚贝<E7989A><E8B49D><EFBFBD>讃<EFBFBD>? 5蝭?
|
||||
- 摨𠉛熙<F0A0899B>? 2蝭<32><E89DAD>獢<EFBFBD><E78DA2>1<EFBFBD><31><EFBFBD>靘?嚗?
|
||||
- 摨娍<E691A8><E5A88D>? 3蝭<33><E89DAD>獢<EFBFBD><E78DA2>3<EFBFBD><33><EFBFBD>靘?<3F><><EFBFBD>靘?嚗?
|
||||
- 瘚贝<E7989A>璅∪<E79285>: 6銝迎<E98A9D>DeepSeek-V3, Qwen-Max, GPT-4o, Claude-4.5嚗?
|
||||
- 测试文献数: 5篇
|
||||
- 应纳入: 2篇(案例1、案例2)
|
||||
- 应排除: 3篇(案例3、案例4、案例5)
|
||||
- 测试模型: 6个(DeepSeek-V3, Qwen-Max, GPT-4o, Claude-4.5)
|
||||
- 测试Prompt: 2种(标准、宽松)
|
||||
|
||||
### B. 完整测试日志
|
||||
|
||||
Reference in New Issue
Block a user